VAP-1 was 5.0 ± 0.3-fold higher in HIV-1 seropositive group with HF as compared to HIV-1 seronegative with no HF and 3.1 ± 0.2-fold higher in HIV-1 seronegative patients with atherosclerosis and HF. This evidence concerns the gene AOC3 and atherosclerosis.